Everest Organics [EVERESTO] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Everest Organics Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Everest Organics Ltd. wins in 5 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Everest Organics Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 52.29 67.11 Everest Organics Ltd.
Price-to-Book Ratio 3.71 10.82 Everest Organics Ltd.
Debt-to-Equity Ratio 68.11 0.58 Divi's Laboratories Ltd.
PEG Ratio -0.71 4.63 Divi's Laboratories Ltd.
EV/EBITDA 18.13 48.63 Everest Organics Ltd.
Profit Margin (TTM) 3.08% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 5.30% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 5.30% 29.65% Divi's Laboratories Ltd.
Return on Equity -1.84% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) -0.57% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-108.03M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -37.06% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.42 16.18 Everest Organics Ltd.
Enterprise Value $3.19B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.69 15.86 Everest Organics Ltd.
Gross Profit Margin (TTM) 38.71% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $197 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $5.29 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.43 0.19 Divi's Laboratories Ltd.

Everest Organics Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

EVERESTO
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Everest Organics Ltd.6.20%-10.00%-11.08%-15.32%-43.80%-53.20%
Divi's Laboratories Ltd.0.30%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Everest Organics Ltd.-37.06%167.84%-27.25%931.92%6,868.83%6,868.83%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Everest Organics Ltd. vs Divi's Laboratories Ltd.

MetricEVERESTODIVISLAB
Market Information
Market Cap i₹2.64B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,482253,443
90 Day Avg. Volume i9,199283,911
Last Close₹248.50₹6,596.50
52 Week Range₹197.00 - ₹536.40₹5,636.50 - ₹7,071.50
% from 52W High-53.67%-6.72%
All-Time High₹536.40 (Jan 02, 2026)₹7,071.50 (Jul 08, 2025)
% from All-Time High-53.67%-6.72%
Growth Metrics
Quarterly Revenue Growth0.02%0.12%
Quarterly Earnings Growth-0.69%-0.01%
Financial Health
Profit Margin (TTM) i0.03%0.24%
Operating Margin (TTM) i0.05%0.30%
Return on Equity (TTM) i-0.02%0.15%
Debt to Equity (MRQ) i68.110.58
Cash & Liquidity
Book Value per Share (MRQ)₹74.65₹580.95
Cash per Share (MRQ)₹1.08₹122.95
Operating Cash Flow (TTM) i₹38.10M₹19.67B
Levered Free Cash Flow (TTM) i₹-12,903,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Everest Organics Ltd. vs Divi's Laboratories Ltd.

MetricEVERESTO (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i52.2967.11
Forward P/E iN/A53.75
PEG Ratio i-0.714.63
Price to Sales (TTM) i1.4216.18
Price to Book (MRQ) i3.7110.82
Market Capitalization
Market Capitalization i₹2.64B₹1.69T
Enterprise Value i₹3.19B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.6915.86
Enterprise to EBITDA i18.1348.63
Risk & Other Metrics
Beta i0.430.19
Book Value per Share (MRQ) i₹74.65₹580.95

Financial Statements Comparison: Everest Organics Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVERESTO (2025)DIVISLAB (2025)
Revenue/Sales i1.59B93.25B
Cost of Goods Sold i985.43M38.70B
COGS % of Revenue i61.8%41.5%
Gross Profit i609.36M54.55B
Gross Margin i38.2%58.5%
Research & Development i8.29M270.00M
Operating Income (EBIT) i23.83M25.71B
Operating Margin i1.5%27.6%
EBITDA i78.09M33.19B
EBITDA Margin i4.9%35.6%
Pre-Tax Income i-32.43M29.16B
Pre-Tax Income % of Revenue i-2.0%31.3%
Income Tax i-19.52M7.25B
Income Tax % of Revenue i-1.2%7.8%
Net Income (Profit) i-12.90M21.91B
Profit Margin i-0.8%23.5%

Balance Sheet & Liquidity Metrics

MetricEVERESTO (2025)DIVISLAB (2025)
Cash & Equivalents i60.92M4.15B
Total Current Assets i1.48B100.81B
Total Current Assets % of Revenue i92.7%108.1%
Total Current Liabilities i1.40B14.52B
Total Current Liabilities % of Revenue i87.7%15.6%
Long-Term Debt i91.98M20.00M
Long-Term Debt % of Revenue i5.8%0.0%
Total Shareholders Equity i699.47M149.69B
Retained Earnings i312.18M134.00B
Retained Earnings % of Revenue i19.6%143.7%
Property, Plant & Equipment i483.39M3.19B

Cash Flow Statement Comparison

MetricEVERESTO (2025)DIVISLAB (2025)
Operating Cash Flow i38.10M19.67B
Operating Cash Flow % of Revenue i2.4%21.1%
Capital Expenditures i-35.77M-14.38B
Free Cash Flow i-108.03M2.15B
FCF Margin i-6.8%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricEVERESTODIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.71M265.47M
Float Shares i978,958117.72M
% Held by Insiders i76.90%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i23.10%19.31%

Dividend Analysis & Yield Comparison: Everest Organics Ltd. vs Divi's Laboratories Ltd.

MetricEVERESTODIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.17₹50.00
3-Year Avg Dividend Yield i0.35%0.70%
3-Year Total Dividends i₹0.50₹150.00
Ex-Dividend DateSep 15, 2022Jul 25, 2025